HODGKINS LYMPHOMA IN PATIENTS OF CERVICAL LYMPHADENOPATHY

被引:0
作者
Rehman, Munir [1 ]
Aslam, Mahpara [2 ]
Ahmad, Ali Ijaz [3 ]
机构
[1] Khyber Teaching Hosp, Peshawar, Kpk, Pakistan
[2] Lahore Gen Hosp, Lahore, Pakistan
[3] Shaikh Zayed Hosp, Lahore, Pakistan
来源
INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2018年 / 5卷 / 11期
关键词
Lymphocytic Diminution; Cervical Lymphadenopathy; Malignant; lymphadenopathy; Biopsy; Nodes; Histopathology;
D O I
10.5281/zenodo.1479217
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: The aim of this research work is to determine the amount of HL (Hodgkin's lymphoma) in cervical abnormal enlargement of the lymph nodes. Methodology: This research work carried out in Mayo hospital Lahore. The duration of the study was from January 2012 to December 2017. The information gathered from the patients suffering of cervical abnormal enlargement of the lymph nodes during the above described study period of five years. All those patients suffering of CL (cervical lyniphadenopathy) underwent to complete previous history, interrogations and assessment with the help of histopathology. Results: There were four hundred and ninety-eight patients suffering of CL in which foray patients found with HL (Hodgkin's lymphoma). Males were making the eighty percent of the total patients. Mixed cellularity was present in more than .fifty percent patients whereas nodular sclerosis was present in more than thirty-seven percent patients. Most of the patients were in the 2 m and 3 rd stage of the disease. The total survival rate in those five years of study period was about seventy-five percent. Conclusion: The amount of the HL in the abnormal enlargement of the lymph nodes in the cervix is very less in our communitiesities as compared to the countries of the West.
引用
收藏
页码:11520 / 11526
页数:7
相关论文
共 26 条
  • [1] Abu eL, 1993, TROP GEOGR MED, V45, P28
  • [2] ERDKAMP FL, 1992, CANCER, V70, P830, DOI 10.1002/1097-0142(19920815)70:4<830::AID-CNCR2820700418>3.0.CO
  • [3] 2-X
  • [4] The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities
    Fujita, M
    Yamashiro, K
    Ichinohasama, R
    Nakamura, N
    Abe, M
    Wakasa, H
    Kojima, M
    Motoori, T
    Izumo, T
    Tamaru, J
    Mikata, A
    Takeuchi, K
    Kakiuchi, C
    Mori, S
    Matsuno, Y
    Nakamura, S
    Yatabe, Y
    Ichimura, K
    Suchi, T
    Tajima, K
    Mori, N
    Takasaki, K
    Tsurumi, K
    Takami, T
    Haga, H
    Sakurai, T
    Yamabe, H
    Kobashi, Y
    Ohsawa, M
    Kanno, H
    Aozasa, K
    Nakamine, H
    Yoshino, T
    Akagi, T
    Sasaki, N
    Namba, K
    Agatsuma, Y
    Iwata, K
    Suzumiya, J
    Ohshima, K
    Kikuchi, M
    Takeshita, M
    Hasui, K
    Sato, E
    Sueyoshi, K
    Tokunaga, M
    [J]. PATHOLOGY INTERNATIONAL, 2000, 50 (09) : 696 - 702
  • [5] CLASSIFICATION OF HODGKINS-DISEASE BIOPSIES BY A PANEL OF 4 HISTOPATHOLOGISTS - REPORT OF 1,140 PATIENTS FROM THE GERMAN NATIONAL TRIAL
    GEORGII, A
    FISCHER, R
    HUBNER, K
    SCHWARZE, EW
    BERNHARDS, J
    [J]. LEUKEMIA & LYMPHOMA, 1993, 9 (4-5) : 365 - 370
  • [6] THE PROGNOSIS OF HODGKINS-DISEASE IN OLDER ADULTS
    GUINEE, VF
    GIACCO, GG
    DURAND, M
    VANDENBLINK, JW
    GUSTAVSSON, A
    MCVIE, JG
    ZEWUSTER, R
    DISCHE, S
    FAHEY, T
    LANE, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (06) : 947 - 953
  • [7] HONG RL, 1992, CANCER-AM CANCER SOC, V69, P1254
  • [8] Kennedy BJ, 1998, CANCER-AM CANCER SOC, V83, P1041, DOI 10.1002/(SICI)1097-0142(19980901)83:5<1041::AID-CNCR31>3.0.CO
  • [9] 2-5
  • [10] KENNEDY BJ, 1985, CANCER, V56, P2547, DOI 10.1002/1097-0142(19851201)56:11<2547::AID-CNCR2820561102>3.0.CO